Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Aniridia-Wilms-tumor syndrome

Aniridia-Wilms-tumor syndrome is an autosomal dominant disorder that is caused by microdeletions including neighboring genes PAX6 and WT1.

Systematic

Wilms tumor
Aniridia-Wilms-tumor syndrome
PAX6
WT1
Denys-Drash syndrome
Somatic nephroblastoma
WAGR syndrome

References:

1.

Vyse TJ et al. (1996) Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice.

external link
2.

Annesi G et al. (2007) SIL1 and SARA2 mutations in Marinesco-Sjögren and chylomicron retention diseases.

external link
3.

Charcosset M et al. (2008) Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein.

external link
4.

Reveille JD et al. (1983) Familial systemic lupus erythematosus: immunogenetic studies in eight families.

external link
5.

Lahita RG et al. (1983) Familial systemic lupus erythematosus in males.

external link
6.

Tan EM et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus.

external link
7.

Reidenberg MM et al. (1980) Acetylator phenotype in idiopathic systemic lupus erythematosus.

external link
8.

Exner T et al. (1980) Familial association of the lupus anticoagulant.

external link
9.

Weinberg JB et al. (1980) Analysis of a large pedigree with elliptocytosis, multiple lipomatosis, and biological false-positive serological test for syphilis.

external link
10.

Morel L et al. (1994) Polygenic control of susceptibility to murine systemic lupus erythematosus.

external link
11.

Sibley JT et al. (1993) Familial systemic lupus erythematosus characterized by digital ischemia.

external link
12.

None (1996) Systemic lupus erythematosus.

external link
13.

Vyse TJ et al. (1996) Genetic analysis of autoimmune disease.

external link
14.

None (1995) Genetics of systemic lupus erythematosus.

external link
15.

Wu J et al. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.

external link
16.

Jones B et al. (2003) Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders.

external link
17.

García CO et al. (1996) Autoantibody profile in African-American patients with lupus nephritis.

external link
18.

Lessard E et al. (1997) Role of CYP2D6 in the N-hydroxylation of procainamide.

external link
19.

Elçioglu N et al. (1998) Maternal systemic lupus erythematosus and chondrodysplasia punctata in two sibs: phenocopy or coincidence?

external link
20.

Austin-Ward E et al. (1998) Neonatal lupus syndrome: a case with chondrodysplasia punctata and other unusual manifestations.

external link
21.

None (1998) Chondrodysplasia punctata and maternal systemic lupus erythematosus.

external link
22.

Gaffney PM et al. (1998) A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families.

external link
23.

Shai R et al. (1999) Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families.

external link
24.

Kelly TE et al. (1999) Chondrodysplasia punctata stemming from maternal lupus erythematosus.

external link
25.

Mohan C et al. (1999) Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies.

external link
26.

Lessard E et al. (1999) Involvement of CYP2D6 activity in the N-oxidation of procainamide in man.

external link
27.

Lindqvist AK et al. (2000) A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q.

external link
28.

Gaffney PM et al. (2000) Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families.

external link
29.

Gross JA et al. (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

external link
30.

Gray-McGuire C et al. (2000) Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2.

external link
31.

Miyake N et al. (2015) Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic Syndrome.

external link
32.

Navon Elkan P et. al. (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.

33.

Bras J et. al. (2014) Mutant ADA2 in vasculopathies.

34.

Van Montfrans JM et. al. (2016) Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.

35.

None (2018) Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2.

36.

Belgareh N et al. (2001) An evolutionarily conserved NPC subcomplex, which redistributes in part to kinetochores in mammalian cells.

external link
37.

Boehmer T et al. (2003) Depletion of a single nucleoporin, Nup107, prevents the assembly of a subset of nucleoporins into the nuclear pore complex.

external link
38.

Zuccolo M et al. (2007) The human Nup107-160 nuclear pore subcomplex contributes to proper kinetochore functions.

external link
39.

Nagai S et al. (2008) Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase.

external link
40.

Zheng X et al. (2012) Loss of zygotic NUP107 protein causes missing of pharyngeal skeleton and other tissue defects with impaired nuclear pore function in zebrafish embryos.

external link
41.

Zhou Q et. al. (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2.

42.

He H et al. (2002) Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues.

external link
43.

Takai Y et al. (2001) Small GTP-binding proteins.

external link
44.

Aguglia U et al. (2000) Vitamin E deficiency due to chylomicron retention disease in Marinesco-Sjögren syndrome.

external link
45.

Johnston AM et al. (2000) SPAK, a STE20/SPS1-related kinase that activates the p38 pathway.

external link
46.

Wang Y et al. (2009) From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene.

external link
47.

Cunnington MS et al. (2009) STK39 polymorphisms and blood pressure: an association study in British Caucasians and assessment of cis-acting influences on gene expression.

external link
48.

Schekman R et al. (1996) Coat proteins and vesicle budding.

external link
49.

Orphanet article

Orphanet ID 442980 external link
50.
51.

Orphanet article

Orphanet ID 118990 external link
52.

NCBI article

NCBI 55212 external link
53.

OMIM.ORG article

Omim 607590 external link
54.

OMIM.ORG article

Omim 607648 external link
55.

NCBI article

NCBI 27347 external link
56.

NCBI article

NCBI 57122 external link
57.

OMIM.ORG article

Omim 607617 external link
58.

Wikipedia article

Wikipedia EN (BBS7) external link
59.

Wikipedia article

Wikipedia EN (STK39) external link
60.

Wikipedia article

Wikipedia EN (Nucleoporin_107) external link
Update: Aug. 14, 2020
Copyright © 2005-2021 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues